DGDevin Gee

Devin Gee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Devin Gee has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Rigorous Female Breast Cancer Phenotyping Using the All of Us Research Program

    by Yuewen Qi, Kassidy Lundy-Perez, Devin Gee, Nyasha Chambwe

    Objectives: Accurate phenotyping of cases and controls is essential for studying biological and environmental contributors to disease in large biobanks. We aimed to develop a flexible, customizable, and reproducible electronic health record (EHR)-based phenotyping framework for identifying disease cases and generating matched control cohorts for downstream analyses. Here, we developed the Phenotyping Algorithm for Cases and matched Controls using EHR-based Rules (PACER). Materials and Methods: Applying PACER to the All of Us Research Program Curated Data Repository v8.0, we identified female breast cancer (BC) cases identified among participants recorded as female at birth using at least two BC-associated diagnostic Observational Medical Outcomes Partnership concept IDs documented at least 30 days apart. A one-to-one matched control cohort was generated by jointly matching on sex, age, genetic ancestry, and state-level residency. Clinical, socioeconomic, and genomic data were integrated for analysis. Results: We identified 10,225 BC cases and generated a control cohort of the same size matched for key demographic characteristics. Comparison with a phecodeX-based BC cohort showed 91.03% agreement. Among cases responding to relevant survey items, 80.86% self-reported a personal history of BC, compared to 1.89% of controls. We detected an enrichment of BC-associated GWAS catalog variants, pathogenic mutations in known risk genes, and higher polygenic risk scores in cases compared to controls. Discussion and Conclusion: Concordance across a phecodeX-based cohort, self-reported survey responses, and genomic analyses supports the validity of PACER-defined cohorts. PACER is publicly available and readily adaptable to other diseases, supporting future research in risk modeling and precision medicine.

  • Open Access

    Endometrial cancer survival disparities in women of African ancestry persist beyond clinical, molecular, and socioeconomic determinants

    by Devin A Gee, Alisha Daroch, Meredith Akerman, Natalie Danziger, Leslie Panella, Megan Gorman, Madeline Bright, Douglas I. Lin, Nyasha Chambwe, Marina Frimer

    Introduction Stark disparities in endometrial cancer (EC) risk and mortality exist between non-Hispanic Black and White women, with Black women experiencing higher incidence and worse survival. This disparity has been attributed to biological and socioeconomic factors, though how these factors interact to influence EC disparities remains unclear. This study modeled EC outcomes using race, area-level socioeconomic deprivation, clinical phenotypes, genetic ancestry, and molecular alterations. Methods We identified 281 cases of EC diagnosed from 2013-2023 in women who underwent clinical genomic sequencing as part of routine care across multiple Northwell Health sites. We estimated genetic ancestry, oncogenic alterations in 324 genes, microsatellite instability, and molecular classification. Geocoded patient addresses were used to derive the state-level Area Deprivation Index to estimate socioeconomic deprivation. Results African ancestry patients were enriched for high-grade disease (89% vs 64%), serous histology (57% vs 26%), and the TP53-mutant molecular classification (71% vs 51%) compared to European ancestry patients (p-valueConclusion Our findings indicate that EC disparities persist after adjusting for socioeconomic, clinical, and molecular factors, highlighting the need to further investigate additional drivers of disparity.

  • Open Access

    Comprehensive Molecular Characterization of High-Grade Endometrial Cancer in an Ancestrally-Diverse Cohort

    by Marina Frimer, Devin Gee, Zoe R Goldstein, WillIam F Hooper, Kyriaki Founta, Astrid Deschenes, Heather Geiger, Pascal Belleau, Melissa Kramer, Brian Yueh, et al.

    Endometrial cancer (EC) exhibits one of the most striking racial disparities in oncology with black women disproportionately affected by aggressive high-grade subtypes that have poorer outcomes. While social and environmental factors undoubtedly contribute, the molecular underpinnings of these disparities remain critically understudied. To bridge this knowledge gap, we performed matched tumor-normal whole-genome sequencing and tumor transcriptome sequencing on 71 predominantly high-grade EC patient samples from an ancestrally diverse cohort of women recruited at a large hospital system in the New York metropolitan area. Our analysis characterized the germline and somatic mutation landscape, identifying ancestry-associated molecular differences. Notably, focal amplification of the EVI1 transcription factor (encoded at the MECOM locus) was significantly more frequent in African ancestry patients and associated with poorer clinical outcomes in an external validation cohort. Additionally transcriptome analysis revealed decreased CD8+ T cell infiltration with increasing African ancestry, suggesting tumor immune microenvironment differences with potential therapeutic implications.

  • Open Access

    Integrative Genomic, Transcriptomic, and Microbiome Profiles of Colon Cancer by Ancestry Provide Insights into Molecular Distinctions

    by Melissa Kramer, Pascal Belleau, Sofia C. Tortora, Astrid Deschenes, Kyriaki Founta, Carino Gurjao, Brian Yueh, Sara Goodwin, Devin Gee, Santhilal Subhash, et al.

    Colorectal cancer (CRC) incidence, tumor biology, and clinical outcomes differ by patient ancestry, yet African ancestry (AFR) populations remain underrepresented in genomic and microbiome studies. Here, we comprehensively characterized genomic, transcriptomic and microbiome features of AFR and European ancestry (EUR) colon cancer patients residing in New York City and Long Island. While confirming known drivers from other large CRC studies, our AFR to EUR comparison of somatic variation also revealed a possible enrichment of functional KRAS variants in AFR tumors. Colon cancer genomes in patients in this study also exhibit distinct patterns of DNA copy number variation, correlating with consensus molecular subtypes. Fusobacterium nucleatum-positive tumors were enriched for co-occurring oral taxa, suggesting an organized oral microbial structure within the tumor microenvironment. Our findings highlight ancestry-associated differences in somatic mutation, copy number variation, and tumor microbiome composition, underscoring the urgent need to expand AFR representation in genomic studies to uncover population-specific determinants of CRC risk and to develop treatment strategies that reflect the full diversity of patients affected by this disease.